Answers are grounded in this paper and cite their sources.
Catalytic photooxygenation of amyloid-β is a leading therapeutic strategy for the treatment of Alzheimer disease; however, the limited tissue permeability of light hampers its clinical application. We here report an alternative catalytic sonooxygenation strategy to circumvent this problem. Amyloid-β aggregates were oxygenated by using rose bengal as a sonosensitizer under ultrasound irradiation. Structure–activity relationships revealed that xanthene-derived catalysts containing halogen atoms furnished a superior amyloid oxygenation activity.
No takes yet. Share an insight, caveat, or question.
Sohma et al. (2023) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: